SARS-CoV-2 Immune Response in Patients With Solid Tumors Receiving Anticancer Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti-Cancer Treatment
Oncologist 2023 Jan 31;[EPub Ahead of Print], K Purshouse, JP Thomson, M Vallet, L Alexander, I Bonisteel, M Brennan, DA Cameron, JD Figueroa, E Furrie, P Haig, M Heck, H McCaughan, P Mitchell, H McVicars, L Primrose, I Silva, K Templeton, N Wilson, PS HallFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.